Pictet Asset Management’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.2M | Buy |
1,079,443
+10,551
| +1% | +$158K | 0.02% | 560 |
|
|
2025
Q1 | $17.2M | Sell |
1,068,892
-23,232
| -2% | -$375K | 0.02% | 532 |
|
|
2024
Q4 | $25.4M | Buy |
1,092,124
+266,418
| +32% | +$6.2M | 0.03% | 436 |
|
|
2024
Q3 | $24.3M | Buy |
825,706
+439,089
| +114% | +$12.9M | 0.03% | 438 |
|
|
2024
Q2 | $9.09M | Buy |
+386,617
| New | +$9.09M | 0.01% | 647 |
|